Biocodex
North America, California, United States, San Bruno
Description
An International Pharmaceutical Company.
Investor Profile
Biocodex has made 5 investments, with 2 in the past 12 months and 20% as lead.
Stage Focus
- Post Ipo Equity (40%)
- Series A (40%)
- Series B (20%)
Country Focus
- France (100%)
Industry Focus
- Biotechnology
- Health Care
- Biopharma
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
